TAMPA, Fla & MINNEAPOLIS--(BUSINESS WIRE)--Biovest International, Inc. (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB: ABPI), today announced that the Naval Health Research Center (NHRC) and Biovest are continuing an ongoing collaboration to study Biovest’s hollow fiber technology. The collaboration is being conducted as a shared resource within the NHRC’s Respiratory Disease Laboratory in San Diego, California. This research collaboration is evaluating the potential use of Biovest’s platform systems for the efficient cell culture production of difficult-to-produce biologics including live viral vaccines, virus-like particles and diagnostic reagents.
